Shlomit Katz-Yust
39 Jabotinsky Street, 4941492
Petah Tiqwa, M 49414, Israel
Petah Tiqwa, M 49414, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Brain metastases in lung cancer patients: Correlation between radiologic phenotypes and outcome parameters in neurosurgically treated cohort.
Journal: The neuroradiology journal
Published: September 04, 2026
Effect of combining targeted therapies or chemotherapy with stereotactic radiosurgery (SRS) on the prognosis of patients with brain metastases from non-small cell lung cancer (NSCLC).
Journal: Journal of neuro-oncology
Published: October 24, 2025
Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulation.
Journal: Blood vessels, thrombosis & hemostasis
Published: October 21, 2025
Do patients with migraine and obesity receive different treatments? Insights from real-world data.
Journal: Headache
Published: June 27, 2025
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: April 18, 2025
Brain tumor classification from FFPE samples using nanopore methylation sequencing.
Journal: NAR cancer
Published: March 19, 2025
Long-term impact of bevacizumab for the treatment of brain radiation necrosis.
Journal: Journal of neuro-oncology
Published: January 03, 2025
Development and validation of the Neuro-Oncology Grief Index.
Journal: Neuro-oncology practice
Published: January 02, 2025
Management of anticoagulation in patients with brain metastasis.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 07, 2024
Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signatures.
Journal: Nature cancer
Published: November 29, 2024
Effect of bevacizumab on refractory meningiomas: 3D volumetric growth rate versus response assessment in neuro-oncology criteria.
Journal: Neuro-oncology advances
Published: October 30, 2024
Last Updated: 09/26/2026